Clinical Trial Update: Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase II clinical trial using genomic and proteomic profiling to guide treatment for metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Sanford Health | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED